Rybelsus (semaglutide) can cause side effects that range from mild to serious. More common side effects include constipation and diarrhea. If side effects from Rybelsus become difficult to ...

Medically reviewed by Lindsay Cook, PharmDMedically reviewed by Lindsay Cook, PharmD When comparing Rybelsus vs. Ozempic, you ...

The FDA approval last Friday of Novo Nordisk’s Rybelsus as the first orally-active GLP-1 agonist is only the first challenge facing the company as it pursues its blockbuster sales targets for ...

Two that often come up? Rybelsus vs. Ozempic. Though both are manufactured by Novo Nordisk and contain semaglutide as the main active ingredient, one is an oral tablet and the other is an ...

The EMA's main advisory committee has backed approval of Novo Nordisk's oral GLP-1 agonist Rybelsus, a key pipeline drug in its type 2 diabetes franchise. Rybelsus (semaglutide) is the first GLP-1 ...

The brands Rybelsus and Ozempic are currently FDA-approved for diabetes management, and Wegovy is used to assist with weight loss. Experts are also interested in other uses of semaglutide.